Nicola Muirhead

University College London

Papers

2

Total Citations

20

H-Index

2

About

Nicola Muirhead is a leading clinical researcher in urological oncology, with a focused expertise in improving surgical outcomes for men with localized prostate cancer. Her major contributions center on the NeuroSAFE technique—a novel approach to robotic-assisted radical prostatectomy (RARP) that uses intraoperative frozen-section analysis to preserve crucial nerve bundles responsible for erectile function and urinary continence. Muirhead is the principal investigator of the landmark NeuroSAFE PROOF trial (2022), a single-blinded, multi-centre, randomized controlled study that rigorously compares NeuroSAFE RARP to standard RARP. This work, which has already garnered over 20 citations, addresses a critical gap in prostate cancer care: reducing the life-altering side effects of surgery without compromising oncological outcomes. By designing a protocol that adheres to the rigorous IDEAL framework for surgical innovation, Muirhead is setting a new standard for evidence-based surgical research. Her dedication to patient quality of life and methodological precision makes her a rising authority in the field, with the potential to reshape clinical practice for thousands of men facing prostate cancer treatment.

Research Focus

Key Achievements

2
H-Index
2
Papers
20
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancer
15 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 30
🏛 Institutions: University College London

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago